A. Menarini Diagnostics. More than just drugs for patients’ health.
As far back as almost 40 years ago, Menarini understood that pharmacological treatments would soon need to be flanked by diagnostic technologies and this intuition led to the birth of the diagnostics division.
At the beginning the activities was focused on the distribution of In Vitro Diagnostics products just in Italy and, from the early 1980s, A. Menarini Diagnostics began to develop and offer a range of innovative systems for the diagnosis, monitoring and prevention of a wide range of diseases and conditions, whilst also establishing a European network of affiliated companies for the promotion of its products and the after-sales service for its customers. It was in this very same period that the R&D department was created, with the aim of designing and developing their own products. A. Menarini Diagnostics has continued to pursue this strategy, both in its own production facility in Pisa and at third-party premises located in all continents, guaranteeing customers instruments and reagents which are not only reliable but also cutting edge.
From just a small handful of people in Italy, A. Menarini Diagnostics has now become a multinational organisation, leader in the European diagnostics sector, with over 1,000 employees and a world-wide presence in no less than 14 countries: Austria, Belgium and Luxembourg, the Netherlands, France, Germany, Greece, Portugal, Italy, Spain, Sweden, the U.K., Ireland and Switzerland.
The range of products that A. Menarini Diagnostics offers is addressed to both patients and healthcare professionals. It includes systems for the self-monitoring of blood glucose and laboratory systems for clinical chemistry, autoimmunity, pathologic anatomy, urinalysis and the measurement of glycated haemoglobin, an important parameter for the diagnosis of Diabetes. Furthermore a range of systems are available for Point of Care Testing and for the laboratories of the veterinary sector.
A. Menarini Diagnostics: almost 40years of safe and sustainable diagnosis, prognosis and prevention.